Yuasa Mari

ユアサマリ | Yuasa Mari

Affiliation and department：
Job title： Assistant Professor
Papers (29)：

Shinya Fujii, Eriko Kikuchi, Honoka Suzuyama, Yuko Watanabe, Mari Ishigami-Yuasa, Hiroyuki Masuno, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida, Hiroyuki Kagechika. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem. 2021
Shunta Nagashima, Junichi Maruyama, Kaori Honda, Yasumitsu Kondoh, Hiroyuki Osada, Makiko Nawa, Ken-Ichi Nakahama, Mari Ishigami-Yuasa, Hiroyuki Kagechika, Haruhiko Sugimura, et al. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells. J Biol Chem. 2021. 297. 1. 100803-100803
Shintaro Sakakitani, Katarzyna A Po, yma-Inoue, Rina Takayama, Kazuki Takahashi, Mari Ishigami-Yuasa, Hiroyuki Kagechika, Hiroyuki Harada, Tetsuro Watabe. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci. 2021. 112. 1. 155-167
Shinya Fujii, Eriko Kikuchi, Yuko Watanabe, Honoka Suzuyama, Mari Ishigami-Yuasa, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida, Hiroyuki Kagechika. Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling. Bioorg. Med. Chem. Lett. 2020. 30. 17. 127408-127408
Hitomi Koga, Mai Negishi, Marie Kinoshita, Shinya Fujii, Shuichi Mori, Mari Ishigami-Yuasa, Emiko Kawachi, Hiroyuki Kagechika, Aya Tanatani. Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore. Int J Mol Sci. 2020. 21. 15. 5584-5584

ｍore...

MISC (1)：

Mari Ishigami-Yuasa, Hiroyuki Kagechika. Chemical Screening of Nuclear Receptor Modulators. Int J Mol Sci. 2020. 21. 15. 1-19

Lectures and oral presentations (45)：

HDAC阻害剤の併用用法がヒト乳がん細胞株に示す増殖阻害効果
(第25回日本がん分子標的治療学会学術集会 2021)
疾患変異型リアノジン受容体を標的とした研究において、リアノジン受容体のサブタイプRyR1,RyR2,RyR3のうちRyR2に着眼したカルシウム誘発性カルシウム放出活性を阻害する新規化合物の創製
(第6回合同シンポジウム「多様な視点を活かして進む~ニューノーマル時代に輝く女性研究者とは?~」文部科学省科学技術人材育成費補助事業「ダイバーシティ研究環境実現イニシアティブ事業(連携型)」 2021)
小胞体内Ca2+濃度測定により新たに同定されたRyR1選択的阻害剤の性質の検討
(第6回日本筋学会学術集会 2020)
ヒト前立腺がん細胞におけるタミバロテンとヒストン脱アセチル化酵素阻害薬の併用効果の検討および作用機序の解明
(第79回日本癌学会学術集会 2020)
小胞体Ca2+評価系に基づいた選択的2型リアノジン受容体抑制剤の創製
(日本薬学会第140年会 2020)

ｍore...

Professional career (2)：

医工学博士
Doctor of Biomedical engineering

Awards (1)：

2020/06 - Shiseido Shiseido Female Researcher Science Grant Development of new retinoid combination therapy that regulates maturation and degradation of RAR protein

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page